You cannot just add patients cdiddy. They will explain all this I'm sure at the conference call. All they said was they are asking to enroll patients using the CD12 sites for this new protocol they filed. Please read the PR. The double-blinded CD-12 study is done and is now an open-label trial....you cannot go back and just add more patients to achieve a higher power but you can do a separate analysis on a separate group of critical patients using the same sites and then do a meta analysis. This conversation is getting slightly ridiculous